Opthea to Host Key Opinion Leader Event on Sozinibercept (OPT-302) in Wet Age-Related Macular Degeneration on April 3, 2024

Stock Information for Optiva Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Optiva Inc.

Opthea Announces Upcoming Presentations at the Retina World Congress 2024
Opthea to Present at the OIS Retina Innovation Summit at ARVO
Opthea Appoints John Han, PharmD, as VP Medical Affairs
Opthea to Participate in the 23?? Annual Needham Virtual Healthcare Conference 
Opthea Appoints Sujal Shah to the Board of Directors
Opthea to Participate in the Leerink Partners Global Biopharma Conference
Opthea Reports Half-Year Financial Results and Business Updates
Opthea Appoints Arshad M. Khanani, MD, MA, FASRS, as Chief Medical Advisor

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.